BVS: Bioventus Inc. Stocks News on November 4, 2025

Do Options Traders Know Something About Bioventus Stock We Don't?

BVS

Zacks

5 months ago

Do Options Traders Know Something About Bioventus Stock We Don't?

Bioventus First Quarter 2025 Earnings: EPS Beats Expectations

BVS

Simply Wall St.

6 months ago

Bioventus First Quarter 2025 Earnings: EPS Beats Expectations

Bioventus Inc (BVS) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Divestitures

BVS

GuruFocus.com

6 months ago

Bioventus Inc (BVS) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Divestitures

BVS

Thomson Reuters StreetEvents

6 months ago

Q1 2025 Bioventus Inc Earnings Call

Bioventus (BVS) Q1 Earnings and Revenues Surpass Estimates

BVS

Zacks

6 months ago

Bioventus (BVS) Q1 Earnings and Revenues Surpass Estimates

BVS

Associated Press Finance

6 months ago

Bioventus: Q1 Earnings Snapshot

Bioventus Reports First Quarter Financial Results

BVS

GlobeNewswire

6 months ago

Bioventus Reports First Quarter Financial Results

Bioventus Inc (BVS) Q1 2025 Earnings Report Preview: What To Look For

BVS

GuruFocus.com

6 months ago

Bioventus Inc (BVS) Q1 2025 Earnings Report Preview: What To Look For

Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025

BVS

GlobeNewswire

6 months ago

Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025

Bioventus Inc. (NASDAQ:BVS) On The Verge Of Breaking Even

BVS

Simply Wall St.

6 months ago

Bioventus Inc. (NASDAQ:BVS) On The Verge Of Breaking Even

Here's Why Bioventus (BVS) Is a Great 'Buy the Bottom' Stock Now

BVS

Zacks

7 months ago

Here's Why Bioventus (BVS) Is a Great 'Buy the Bottom' Stock Now

Bioventus (BVS) Upgraded to Buy: Here's What You Should Know

BVS

Zacks

8 months ago

Bioventus (BVS) Upgraded to Buy: Here's What You Should Know

Bioventus Full Year 2024 Earnings: Beats Expectations

BVS

Simply Wall St.

8 months ago

Bioventus Full Year 2024 Earnings: Beats Expectations

BVS

Thomson Reuters StreetEvents

8 months ago

Q4 2024 Bioventus Inc Earnings Call

Bioventus Inc (BVS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Debt ...

BVS

GuruFocus.com

8 months ago

Bioventus Inc (BVS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Debt ...

Bioventus (BVS) Q4 Earnings and Revenues Surpass Estimates

BVS

Zacks

8 months ago

Bioventus (BVS) Q4 Earnings and Revenues Surpass Estimates

BVS

MT Newswires

8 months ago

Bioventus Q4 Adjusted Earnings, Revenue Rise; 2025 Outlook Set

BVS

Associated Press Finance

8 months ago

Bioventus: Q4 Earnings Snapshot

Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results

BVS

GlobeNewswire

8 months ago

Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results

Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025

BVS

GlobeNewswire

8 months ago

Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025

Recursion Pharmaceuticals (RXRX) Stock Jumps 8.9%: Will It Continue to Soar?

BVS

Zacks

9 months ago

Recursion Pharmaceuticals (RXRX) Stock Jumps 8.9%: Will It Continue to Soar?

With 32% ownership, Bioventus Inc. (NASDAQ:BVS) has piqued the interest of institutional investors

BVS

Simply Wall St.

9 months ago

With 32% ownership, Bioventus Inc. (NASDAQ:BVS) has piqued the interest of institutional investors

Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference

BVS

GlobeNewswire

10 months ago

Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference

BVS Stock Gains Post Divestiture of Advanced Rehabilitation Business

BVS

Zacks

10 months ago

BVS Stock Gains Post Divestiture of Advanced Rehabilitation Business

Bioventus completes divestiture of its Advanced Rehabilitation business

BVS

TipRanks

10 months ago

Bioventus completes divestiture of its Advanced Rehabilitation business

BVS

MT Newswires

10 months ago

Bioventus Sells Advanced Rehabilitation Business to Accelmed Partners

Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

BVS

GlobeNewswire

10 months ago

Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

Is Bioventus (BVS) Outperforming Other Medical Stocks This Year?

BVS

Zacks

10 months ago

Is Bioventus (BVS) Outperforming Other Medical Stocks This Year?

BVS

MT Newswires

a year ago

JPMorgan Upgrades Bioventus to Neutral From Underweight, Adjusts Price Target to $13 From $12

Wall Street Analysts Think Bioventus (BVS) Could Surge 26.03%: Read This Before Placing a Bet

BVS

Zacks

a year ago

Wall Street Analysts Think Bioventus (BVS) Could Surge 26.03%: Read This Before Placing a Bet

BVS

Thomson Reuters StreetEvents

a year ago

Q3 2024 Bioventus Inc Earnings Call

Bioventus Inc (BVS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...

BVS

GuruFocus.com

a year ago

Bioventus Inc (BVS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ...

BVS

MT Newswires

a year ago

Bioventus' Shares Down in Early Trading Amid Higher Q3 Results

Bioventus (BVS) Matches Q3 Earnings Estimates

BVS

Zacks

a year ago

Bioventus (BVS) Matches Q3 Earnings Estimates

BVS

Associated Press Finance

a year ago

Bioventus: Q3 Earnings Snapshot

Bioventus Reports Third Quarter Financial Results

BVS

GlobeNewswire

a year ago

Bioventus Reports Third Quarter Financial Results

Are Medical Stocks Lagging Bioventus (BVS) This Year?

BVS

Zacks

a year ago

Are Medical Stocks Lagging Bioventus (BVS) This Year?

Bioventus Inc (BVS) Q3 2024 Earnings Report Preview: What To Look For

BVS

GuruFocus.com

a year ago

Bioventus Inc (BVS) Q3 2024 Earnings Report Preview: What To Look For

Should Bioventus Stock Be in Your Portfolio Pre-Q3 Earnings?

BVS

Zacks

a year ago

Should Bioventus Stock Be in Your Portfolio Pre-Q3 Earnings?

Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024

BVS

GlobeNewswire

a year ago

Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024

BVS

MT Newswires

a year ago

Bioventus Files $200 Million Mixed-Shelf Offering

Bioventus Surges 73% in Three Months: Time to Buy the Stock?

BVS

Zacks

a year ago

Bioventus Surges 73% in Three Months: Time to Buy the Stock?

Are Medical Stocks Lagging ChromaDex (CDXC) This Year?

BVS

Zacks

a year ago

Are Medical Stocks Lagging ChromaDex (CDXC) This Year?

BVS

Investor's Business Daily

a year ago

Solventum Stock Earns 81 RS Rating

Bioventus Inc (BVS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

BVS

GuruFocus.com

a year ago

Bioventus Inc (BVS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

BVS

MT Newswires

a year ago

Bioventus to Sell Advanced Rehabilitation Business to Accelmed Partners

Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

BVS

GlobeNewswire

a year ago

Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners

ABBV's Newly Added Parkinson's Disease Drug Meets Second Study Goal

BVS

Zacks

a year ago

ABBV's Newly Added Parkinson's Disease Drug Meets Second Study Goal

Pfizer Withdraws Sickle Cell Disease Therapy Oxbryta From Market

BVS

Zacks

a year ago

Pfizer Withdraws Sickle Cell Disease Therapy Oxbryta From Market

CHMP Endorses AstraZeneca's Fasenra in Rare Autoimmune Disease

BVS

Zacks

a year ago

CHMP Endorses AstraZeneca's Fasenra in Rare Autoimmune Disease

BVS

Zacks

a year ago

Zacks.com featured highlights include Bioventus, Great Lakes Dredge & Dock and AxoGen

First September Gains in 5 Years? Buy 3 Breakout Stocks Now

BVS

Zacks

a year ago

First September Gains in 5 Years? Buy 3 Breakout Stocks Now

Longboard Stock Soars on FDA Designations for Epilepsy Drug

BVS

Zacks

a year ago

Longboard Stock Soars on FDA Designations for Epilepsy Drug

GSK Meets Study Goal for Co-Administered RSV-Shingles Vaccines

BVS

Zacks

a year ago

GSK Meets Study Goal for Co-Administered RSV-Shingles Vaccines

Bioventus Surges 103% in Six Months: Is the Stock Worth a Buy?

BVS

Zacks

a year ago

Bioventus Surges 103% in Six Months: Is the Stock Worth a Buy?

Ascendis Soars on Encouraging Data From Dwarfism Drug Study

BVS

Zacks

a year ago

Ascendis Soars on Encouraging Data From Dwarfism Drug Study

Xencor Stock Gains 23% on Encouraging Pipeline Advancements

BVS

Zacks

a year ago

Xencor Stock Gains 23% on Encouraging Pipeline Advancements

Summit Hits Record High on Lung Cancer Drug Topping Merck's Keytruda

BVS

Zacks

a year ago

Summit Hits Record High on Lung Cancer Drug Topping Merck's Keytruda

BioMarin Posts '27 Biz View, Outlines Growth Plans for Next 10 Years

BVS

Zacks

a year ago

BioMarin Posts '27 Biz View, Outlines Growth Plans for Next 10 Years

JNJ Seeks First FDA Nod for Autoimmune Disease Drug Nipocalimab

BVS

Zacks

a year ago

JNJ Seeks First FDA Nod for Autoimmune Disease Drug Nipocalimab

Merck Scraps Two Late-Stage Keytruda Studies on Disappointing Data

BVS

Zacks

a year ago

Merck Scraps Two Late-Stage Keytruda Studies on Disappointing Data

BVS

Zacks

a year ago

Bull Of The Day: Bioventus (BVS)

BVS

Zacks

a year ago

Bioventus and Pool have been highlighted as Zacks Bull and Bear of the Day

Pfizer Follows Lilly's Example, Unveils DTC Service for Selling Drugs

BVS

Zacks

a year ago

Pfizer Follows Lilly's Example, Unveils DTC Service for Selling Drugs

Soleno Stock Up as FDA Accepts PWS Drug NDA Under Priority Review

BVS

Zacks

a year ago

Soleno Stock Up as FDA Accepts PWS Drug NDA Under Priority Review

Insmed Stock Surges 168% in the Past Six Months: Here's Why

BVS

Zacks

a year ago

Insmed Stock Surges 168% in the Past Six Months: Here's Why

AstraZeneca (AZN) Denies Rumors About UK Facility Relocation

BVS

Zacks

a year ago

AstraZeneca (AZN) Denies Rumors About UK Facility Relocation

Why Grifols (GRFS) Stock Price Moved Up 7% on Wednesday

BVS

Zacks

a year ago

Why Grifols (GRFS) Stock Price Moved Up 7% on Wednesday

BVS

Zacks

a year ago

Zacks Industry Outlook Highlights Corcept, Amneal, Bioventus, Foghorn and Akebia

5 Small Drug Stocks to Buy as Innovation Reaches Peak

BVS

Zacks

a year ago

5 Small Drug Stocks to Buy as Innovation Reaches Peak

Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference

BVS

GlobeNewswire

a year ago

Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference

Bioventus Reports Second Quarter Financial Results

BVS

GlobeNewswire

a year ago

Bioventus Reports Second Quarter Financial Results

Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024

BVS

GlobeNewswire

a year ago

Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024

Merck (MRK) Gets Exclusive Rights to Opevesostat From Partner

BVS

Zacks

a year ago

Merck (MRK) Gets Exclusive Rights to Opevesostat From Partner

Italian energy company targets Britain for fleet of 20 mini-nukes

BVS

The Telegraph

a year ago

Italian energy company targets Britain for fleet of 20 mini-nukes

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

BVS

Motley Fool

a year ago

4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow

Seoul resumes loudspeaker propaganda against North

BVS

AFP

a year ago

Seoul resumes loudspeaker propaganda against North

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

BVS

Simply Wall St.

a year ago

Barnes Group's (NYSE:B three-year decrease in earnings delivers investors with a 29% loss

American Software Full Year 2024 Earnings: EPS Beats Expectations

BVS

Simply Wall St.

a year ago

American Software Full Year 2024 Earnings: EPS Beats Expectations

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

BVS

Simply Wall St.

a year ago

Harley-Davidson (NYSE:HOG) Hasn't Managed To Accelerate Its Returns

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

BVS

Simply Wall St.

a year ago

Best Buy First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

3 Mistakes That Can Get Your Costco Membership Canceled

BVS

Motley Fool

a year ago

3 Mistakes That Can Get Your Costco Membership Canceled

Lotto 6/49 - $64 million up for grabs in the next draw!

BVS

CNW Group

a year ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

BVS

Simply Wall St.

a year ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North

BVS

AFP

a year ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

BVS

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

BVS

Simply Wall St.

a year ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

BVS

Barrons.com

a year ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

BVS

Simply Wall St.

a year ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

BVS

Simply Wall St.

a year ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

Here's Why You Should Consider Buying Bioventus (BVS) Stock

BVS

Zacks

a year ago

Here's Why You Should Consider Buying Bioventus (BVS) Stock

J&J (JNJ) Seeks Expanded Use of HIV Drug in US and Europe

BVS

Zacks

a year ago

J&J (JNJ) Seeks Expanded Use of HIV Drug in US and Europe

Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody

BVS

Zacks

a year ago

Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody

Merck (MRK) to Buy Private Ophthalmology Company EyeBio

BVS

Zacks

a year ago

Merck (MRK) to Buy Private Ophthalmology Company EyeBio

J&J (JNJ) to Buy Rights to Novel Atopic Dermatitis Candidate

BVS

Zacks

a year ago

J&J (JNJ) to Buy Rights to Novel Atopic Dermatitis Candidate

Bioventus Inc. (NASDAQ:BVS) Q1 2024 Earnings Call Transcript

BVS

Insider Monkey

a year ago

Bioventus Inc. (NASDAQ:BVS) Q1 2024 Earnings Call Transcript

BVS

GuruFocus.com

a year ago

Bioventus Inc (BVS) Q1 2024 Earnings Call Transcript Highlights: Strong Start with Significant ...

BVS

Thomson Reuters StreetEvents

a year ago

Q1 2024 Bioventus Inc Earnings Call

BVS

GlobeNewswire

a year ago

Bioventus Reports First Quarter Financial Results

Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024

BVS

GlobeNewswire

2 years ago

Latest Bioventus Inc. (BVS) News on November 4, 2025

Share on Social Networks: